首页> 外文期刊>Orthopedics >Metal-on-metal total hip arthroplasty: Causes and high incidence of early failure
【24h】

Metal-on-metal total hip arthroplasty: Causes and high incidence of early failure

机译:金属对金属全髋关节置换术:早期失败的原因和高发生率

获取原文
获取原文并翻译 | 示例
           

摘要

Early failures of metal-on-metal total hip arthroplasty (THA) occur due to aseptic loosening, metal hypersensitivity reactions, pseudotumor formation, and component seizing. The purpose of this study was to investigate the timing, common modes of failure, clinical outcomes, and incidence of metal-on-metal THA revisions. A review was performed of 80 patients who underwent revision of a failed metal-on-metal THA for any reason. The most common reason for metal-on-metal failure was aseptic acetabular loosening, with a rate of 56.25% (45/80 patients). Early failure of metal-on-metal THAs was noted, with 78% of these revisions being performed within 2 years of the index operation and 92.5% within 3 years. Furthermore, 13% of patients experienced significant localized soft tissue reactions. Mean preoperative Harris Hip Score was 42.35±14.24 and mean postoperative Harris Hip Score was 66.5±23.2 (range, 9.55-95.4), with an average follow-up of 438±492 days (range, 40-2141), or 1.2 years. It is imperative that clinicians be cognizant of the fact that the proposed advantages of metal-on-metal THA are not without potential detrimental sequelae. This article proposes an algorithm to aid in diagnosing the etiology of a painful metal-on-metal THA, as well as 2 classification schemes regarding metal-on-metal THA complications to help direct treatment.
机译:金属对金属的全髋关节置换术(THA)的早期失效是由于无菌性松动,金属超敏反应,假瘤形成和部件卡死引起的。这项研究的目的是调查金属对金属THA修订的时间,常见失败模式,临床结果和发生率。回顾了80例因任何原因接受金属对金属THA修复失败的患者。金属对金属失效的最常见原因是无菌性髋臼松弛,发生率为56.25%(45/80例)。注意到金属对金属THA的早期失效,其中78%的修订是在指数运行的2年内执行的,而92.5%的修订是在3年内执行的。此外,13%的患者经历了明显的局部软组织反应。术前平均Harris髋关节评分为42.35±14.24,术后平均Harris髋关节评分为66.5±23.2(范围9.55-95.4),平均随访438±492天(范围40-2141)或1.2年。临床医生必须意识到以下事实,即金属对金属THA的拟议优势并非没有潜在的有害后遗症。本文提出了一种算法,可帮助诊断痛苦的金属对THA的病因,以及针对金属对THA并发症的两种分类方案,以帮助直接治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号